China Biotech Services Holdings Limited
Research China Biotech Services Holdings Limited (8037.HK) on Bullrun: market cap HKD 495.34M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker8037.HK
- ExchangeHK
- CountryHong Kong
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyHKD
- Market capHKD 495.34M
- Financial periodFY2025
- RevenueHKD 73.50M
- Revenue growth4.2%
- Net income-HKD 68.78M
- Free cash flow-HKD 191.44M
- Gross margin10.5%
Valuation Snapshot
latest market cap is HKD 495.34M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | HKD 73.50M | -HKD 68.78M | -HKD 191.44M | 10.5% | -0.07 | HKD 12.08M | HKD 394.90M | HKD 191.41M |
| FY2024 | HKD 70.51M | -HKD 198.15M | -HKD 203.54M | -7.0% | -0.21 | HKD 18.91M | HKD 187.83M | HKD 264.94M |
| FY2023 | HKD 211.99M | -HKD 95.45M | HKD 132.31M | 16.2% | -0.1 | HKD 72.09M | HKD 100.40M | HKD 462.75M |
| FY2022 | HKD 1.85B | HKD 258.09M | HKD 361.23M | 59.5% | 0.27 | HKD 92.77M | HKD 81.78M | HKD 602.68M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | HKD 495.34M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 HKD.
| Year | Dividends/share |
|---|---|
| FY2023 | 0.01 HKD |
About China Biotech Services Holdings Limited
China Biotech Services Holdings Limited, an investment holding company, provides medical laboratory testing and health check services in the People's Republic of China and Hong Kong. The company operates through Medical and Health Related Services, Immunotherapy, Pharmaceutical Products, Insurance Brokerage, BNCT, and Others segments. It also engages in the provision of tumor immune cell therapy and health management services; sale and distribution of health related and pharmaceutical products;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is China Biotech Services Holdings Limited's market cap?
China Biotech Services Holdings Limited's market capitalization is HKD 495.34M.
What does China Biotech Services Holdings Limited do?
China Biotech Services Holdings Limited, an investment holding company, provides medical laboratory testing and health check services in the People's Republic of China and Hong Kong. The company operates through Medical and Health Related Services, Immunotherapy, Pharmaceutical Products, Insurance Brokerage, BNCT, and Others segments.